| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | SVP, Discovery | Common Stock | 74,520 | $46,947 | $0.6300 | 01 Jun 2025 | Direct |
| LEXICON PHARMACEUTICALS, INC. | SVP, Discovery | Stock Option (Right to Buy) | 357,680 | 12 Feb 2026 | Direct | ||
| LEXICON PHARMACEUTICALS, INC. | SVP, Discovery | Restricted Stock Units | 238,450 | 12 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | 12 Feb 2026 | 2 | $0 | 4 | SVP, Discovery | 17 Feb 2026, 16:08 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 01 Jun 2025 | 0 | $0 | 3 | SVP, Discovery | 09 Jun 2025, 10:03 |